Baker Brothers Advisors - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 121 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$1,107,000
+63.0%
522,360
-10.0%
0.00%
+33.3%
Q3 2020$679,000
+29.3%
580,4000.0%0.00%
+50.0%
Q2 2020$525,000
+8.0%
580,4000.0%0.00%
-33.3%
Q1 2020$486,000
-12.7%
580,4000.0%0.00%0.0%
Q4 2019$557,000
-6.9%
580,4000.0%0.00%
-25.0%
Q3 2019$598,000
-42.8%
580,4000.0%0.00%
-42.9%
Q2 2019$1,045,000
-4.2%
580,4000.0%0.01%0.0%
Q1 2019$1,091,000
+59.3%
580,4000.0%0.01%
+16.7%
Q4 2018$685,000
-56.5%
580,4000.0%0.01%
-40.0%
Q3 2018$1,573,000
+41.8%
580,4000.0%0.01%
+25.0%
Q2 2018$1,109,000
-9.0%
580,4000.0%0.01%
-20.0%
Q1 2018$1,219,000
+3.5%
580,4000.0%0.01%0.0%
Q4 2017$1,178,000
+52.6%
580,4000.0%0.01%
+66.7%
Q3 2017$772,000
-15.3%
580,4000.0%0.01%
-25.0%
Q2 2017$911,000
-51.4%
580,4000.0%0.01%
-46.7%
Q1 2017$1,875,000
+139.2%
580,4000.0%0.02%
+87.5%
Q4 2016$784,000
-13.4%
580,4000.0%0.01%0.0%
Q3 2016$905,000
-78.8%
580,400
+90.3%
0.01%
-77.1%
Q1 2015$4,264,000
-19.1%
305,037
-2.2%
0.04%
-35.2%
Q4 2014$5,270,000
+25.9%
312,0250.0%0.05%
+1.9%
Q3 2014$4,187,000
-47.3%
312,025
-50.0%
0.05%
-45.4%
Q2 2014$7,950,000
+7.1%
624,0500.0%0.10%
+3.2%
Q1 2014$7,420,000
-27.5%
624,050
+6.3%
0.09%
-35.2%
Q3 2013$10,230,000
-37.8%
586,936
-42.3%
0.14%
-55.5%
Q2 2013$16,458,0001,016,4330.33%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
BVF INC/IL 7,866,108$25,408,0004.32%
Nine Chapters Capital Management LLC 91,500$296,0000.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,969,225$6,361,0000.24%
Orbimed Advisors 3,250,300$10,498,0000.12%
PINNACLE ASSOCIATES LTD 1,306,679$4,221,0000.08%
PLATINUM INVESTMENT MANAGEMENT LTD 810,232$2,617,0000.07%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 270,417$873,0000.06%
Rock Springs Capital Management LP 270,000$872,0000.05%
ALGERT GLOBAL LLC 39,876$129,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 391,671$1,265,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders